Wearable Cardiomechanics Monitor to Decrease Heart Failure Readmissions

可穿戴式心脏力学监测仪可减少心力衰竭再入院率

• 批准号: 9144990
• 负责人: Omer Tolga Inan
• 金额: $ 61.64万
• 依托单位: GEORGIA INSTITUTE OF TECHNOLOGY
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-09-30 至 2017-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9144990
• 关键词: Address; Affect; Algorithms; American; Arrhythmia; Cardiac; Cardiac Output; Cardiovascular Diseases; Cardiovascular system; Caregivers; Caring; Chest; Chronic; Clinic; Clinical; Complex; Computational Technique; Data; Data Set; Diagnosis; Diagnostic; Disease; Elderly; Electrocardiogram; Electronics; Environment; Exercise; Feedback; Goals; Health; Health Care Costs; Heart failure; Heating; Home environment; Hospitalization; Hospitals; Incidence; Internet; Knowledge; Lead; Life; Literature; Measurement; Measures; Mechanics; Medicare; Methods; Mining; Monitor; Morbidity - disease rate; Morphologic artifacts; Motion; Outcome; Participant; Patient Monitoring; Patients; Physiological; Physiology; Population; Quality of life; Randomized Controlled Trials; Research; Resolution; Risk; Sensitivity and Specificity; Series; Signal Transduction; Sleep; Societies; Solutions; Surface; Symptoms; System; Techniques; Technology; Time; Validation; Wireless Technology; Work; base; clinically relevant; cost; design; experience; hemodynamics; improved; innovation; meetings; monitoring device; mortality; novel; novel strategies; older patient; prevent; prototype; response; scale up; sensor; stressor; stroke rehabilitation; tool; vibration

 DESCRIPTION (provided by applicant): Heart failure (HF) is one of the most major challenges faced by society today, claiming hundreds of thousands of American lives each year and costing more than 30 billion Medicare dollars annually. The ultimate goal of this research is to create a non-invasive and unobtrusive system for monitoring HF patients at home, automatically assessing their risk of experiencing an exacerbation, and providing feedback to caregivers and the patients themselves. This will enable proactive management of HF at home, with patients receiving tailored therapies that can adapt continuously to meet their changing needs. The hypothesis is that by (1) measuring a combination of hemodynamics, activity, and cardiovascular response to stressors (e.g. exercise) at home, and (2) combining these heterogeneous measures with modern data analytics, prediction of HF exacerbation at home can be achieved with a predictive window of greater than 7 days before impending hospitalization. To examine this hypothesis, the following four specific aims are proposed: (1) to collect longitudinal hemodynamic (ballistocardiogram, BCG) and activity data unobtrusively at home for the first time in a population of elderly HF patients; (2) to adapt existing algorithms fo predicting an impending HF exacerbation based on BCG, ECG, and activity time series data; (3) to develop wearable hardware based on BCG to be used at home for continuous hemodynamic and activity recording from elderly HF patients; and (4) to develop innovative sensing strategies and algorithms for improving the robustness of wearable BCG measurements. A previously demonstrated and verified weighing scale for center-of-mass (COM) BCG measurement will be scaled-up and deployed in the home of 200 total patients over the course of the project. Simultaneously, the hardware and analytics efforts will build on our prior data and existing prototypes. For the first 25 participants in the take-home BCG study, we will also conduct a direct physiologic study to quantify the underlying mechanisms contributing to both the scale-based (COM) and wearable BCG measurements, and to develop computational techniques for converting between the two domains (COM versus surface vibrations of the chest). These techniques, in combination with iterative and experimental efforts to improve the robustness of wearable BCG measurements, will then be applied to optimizing the wearable system for BCG and activity monitoring. This system will then be scaled-up and deployed in the home for the final 50 participants (of 200) in the take-home study. While we anticipate that the wearable will provide the best solution, the project risk is mitigated through the validation efforts with the existing scale-based system. Successful completion of this project could ultimately reduce HF related hospitalizations, and thus both improve quality of life for elderly Americans, and reduce overall healthcare costs.